Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.24 USD
Change Today +0.23 / 0.96%
Volume 151.2K
CSII On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

cardiovascular systems inc (CSII) Snapshot

Open
$23.81
Previous Close
$24.01
Day High
$24.35
Day Low
$23.65
52 Week High
04/10/15 - $41.28
52 Week Low
08/12/15 - $22.33
Market Cap
787.3M
Average Volume 10 Days
346.5K
EPS TTM
$-1.04
Shares Outstanding
32.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOVASCULAR SYSTEMS INC (CSII)

cardiovascular systems inc (CSII) Related Bloomberg News

View More Bloomberg News

cardiovascular systems inc (CSII) Related Businessweek News

No Related Businessweek News Found

cardiovascular systems inc (CSII) Details

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Diamondback 360 60cm Peripheral OAS access device, and the 4 Diamondback 360 French 1.25 Peripheral OAS access device products for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with existing surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, a catheter-based platform to facilitate stent delivery in patients with coronary artery disease. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

cardiovascular systems inc (CSII) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.1M
Chief Financial Officer
Total Annual Compensation: $330.7K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $305.4K
Chief Healthcare Policy Officer
Total Annual Compensation: $318.7K
Chief Administrative Officer, Compliance Offi...
Total Annual Compensation: $296.4K
Compensation as of Fiscal Year 2014.

cardiovascular systems inc (CSII) Key Developments

Cardiovascular Systems Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2015; Provides Earnings Guidance for the First Quarter of 2016

Cardiovascular Systems Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2015. For the quarter, the company reported revenues of $48,454,000 compared to $39,564,000 a year ago. Loss from operations was $8,652,000 compared to $9,554,000 a year ago. Net loss was $8,669,000 or $0.27 per basic and diluted share compared to $9,628,000 or $0.31 per basic and diluted share a year ago. Adjusted LBITDA was $4,069,000 compared to $5,923,000 a year ago. For the year, the company reported revenues of $181,544,000 compared to $136,612,000 a year ago. Loss from operations was $32,637,000 compared to $33,489,000 a year ago. Net loss was $32,822,000 or $1.04 per basic and diluted share compared to $35,290,000 or $1.25 per basic and diluted share a year ago. Adjusted LBITDA was $15,598,000 compared to $21,194,000 a year ago. The company provided earnings guidance for the first quarter of 2016. The company expects revenue growth of 23% to 27% over the first quarter of fiscal 2015, excluding Asahi guide wire sales in the prior period, to a range of $48.5 million to $50.0 million. Net loss expects to be in the range of $12.0 million to $12.9 million, or loss per common share ranging from $0.38 to $0.40, assuming 32.0 million average shares outstanding.

Cardiovascular Systems Inc. to Report Q4, 2015 Results on Aug 05, 2015

Cardiovascular Systems Inc. announced that they will report Q4, 2015 results at 3:45 PM, Central Standard Time on Aug 05, 2015

Cardiovascular Systems Inc., Q4 2015 Earnings Call, Aug 05, 2015

Cardiovascular Systems Inc., Q4 2015 Earnings Call, Aug 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSII:US $24.24 USD +0.23

CSII Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $25.50 USD -0.77
CryoLife Inc $9.90 USD +0.26
Endologix Inc $13.04 USD +0.08
Spectranetics Corp/The $17.21 USD +0.38
Vascular Solutions Inc $35.07 USD -0.42
View Industry Companies
 

Industry Analysis

CSII

Industry Average

Valuation CSII Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.2x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOVASCULAR SYSTEMS INC, please visit www.csi360.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.